Pain Management, Opioid Policies Recommended by NACDS As CMS studies the treatment and prevention of opioid addiction, NACDS submits comments on addressing the epidemic and caring for pain sufferers

By |2019-10-17T15:25:43-05:00Oct-17-19|Categories: Press Release|Tags: , |

As the Centers for Medicare & Medicaid Services studies the treatment and prevention of opioid addiction, NACDS has submitted comments on addressing the epidemic and caring for pain sufferers.

As HHS’ Azar Testifies, NACDS Urges His DIR Reform Proposals NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement

By |2019-06-19T12:26:21-05:00Mar-14-19|Categories: Press Release|Tags: , , , , , |

NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement.

NACDS Urges DIR Fee Reform in Morning Consult Op-Ed NACDS President & CEO Steven C. Anderson emphasizes DIR fee reform’s role in lowering patients’ out of pocket costs, reducing overall healthcare costs

By |2019-06-19T12:03:06-05:00Mar-08-19|Categories: Press Release|Tags: , , , , , |

Morning Consult today published an opinion piece by the NACDS entitled “DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs.”

NACDS Urges DIR Fee Reform in Statement to House Ways and Means Committee Details opportunities to reduce patients’ out-of-pocket drug costs and to lower overall healthcare spending through DIR fee reform; Describes public’s trust of pharmacies’ cost-saving proposals

By |2019-10-22T11:01:51-05:00Feb-12-19|Categories: Press Release|Tags: , , , , |

NACDS today submitted a statement to the U.S. House of Representatives Committee on Ways and Means for the hearing titled “The Cost of Rising Prescription Drug Prices.”

NACDS, NCPA Thank Patient, Consumer Groups for Taking Important Stance on DIR Fee Reform Groups emphasize DIR fee reform’s power to reduce out-of-pocket drug costs and to reduce overall healthcare costs as a result of medication adherence and better health

By |2019-06-24T19:40:04-05:00Feb-12-19|Categories: Press Release|Tags: , , , , |

NACDS and the National Community Pharmacists Association (NCPA) today lauded 24 patient and consumer groups for advocating for pharmacy direct and indirect remuneration (DIR) fee reform.